SOD1 and irritable bowel syndrome: As in the case of GPx enzymatic activity, we obtained a significant decrease in SOD activity for the IBS group as compared to the control group (F(1, 11) = 8.73, p = 0.013) and to the extract-treated group (F(1, 14) = 20.46, p = 0.00047) (Figure 8).